Pfizer confronts ‘peak of anti-vaccination rhetoric’ as shares rebound

Cost-saving program "will touch all parts of the business" but won't affect Seagen acquisition, Pfizer says.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.